Forty Seven (Series A)
Funding Details
Awarder
Inbox
Date Award
February 24, 2016
Vertical
Immuno-oncology
Funding URL
View Funding Page
Funding Amount
$75,000,000
Company Info
Market
Cancer treatment
Location
Menlo Park, CA, USA
Coinvestors
Clarus Ventures, Sutter Hill Ventures
Company Description

Forty Seven is a clinical-stage immuno-oncology company that is developing therapies targeting cancer immune evasion pathways.

Links
WebsiteCrunchbaseLinkedIn
Back to HomeBack to Immuno-oncology DealsView Funding Announcement